CHOI, Chul Yung,PAN, Sang O.,SEOL, Hee Jin,LEE, Gyu Ok,PARK, Ka Hyon,KIM, Hee Sook,JANG, Wook Jin,KIM, Hyun,LEE, Dong Wook,KIM, Sun Oh,KIM, Jae Gap
申请号：
AU2016201841
公开号：
AU2016201841B2
申请日:
2016.03.23
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016201841B220171102.pdf#####ABSTRACT OF THE DISCLOSURE Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. 5 The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia 0 Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
